MedTrace Logo

Normobaric Oxygen (NBO) Therapy in Acute Migraine

NCT01542307 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2017-03-27

Study results available
· View outcomes & findings →

Summary

This is a pilot study investigating the therapeutic potential of breathing 100% oxygen in acute migraine headache.

Conditions

Interventions

BIOLOGICAL

Oxygen

Oxygen is inhaled for 30 minutes during migraine attack

BIOLOGICAL

Room air

Placebo

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Aneesh B Singhal, MD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01542307 on ClinicalTrials.gov